ARIZ Announces Grant of Key US Patent
August 20, 2024
DAVIS, CALIFORNIA, UNITED STATES, August 20, 2024 /EINPresswire.com/ -- ARIZ Precision Medicine, Inc., a preclinical stage biopharmaceutical company developing precision ligand targeted siRNA cancer therapies, today announced the issuance of a broad patent for a highly specific drug candidate (ARIZ...